CS89592A3 - Novel indole derivative, process of its preparation and a pharmaceuticalcomprising thereof - Google Patents
Novel indole derivative, process of its preparation and a pharmaceuticalcomprising thereof Download PDFInfo
- Publication number
- CS89592A3 CS89592A3 CS92895A CS89592A CS89592A3 CS 89592 A3 CS89592 A3 CS 89592A3 CS 92895 A CS92895 A CS 92895A CS 89592 A CS89592 A CS 89592A CS 89592 A3 CS89592 A3 CS 89592A3
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- phenyl
- indolyl
- methyl
- urea
- diisopropyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9103618A FR2674522B1 (fr) | 1991-03-26 | 1991-03-26 | Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS89592A3 true CS89592A3 (en) | 1992-10-14 |
Family
ID=9411107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS92895A CS89592A3 (en) | 1991-03-26 | 1992-03-25 | Novel indole derivative, process of its preparation and a pharmaceuticalcomprising thereof |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US5219859A (es) |
| EP (1) | EP0506532B1 (es) |
| JP (1) | JPH0597802A (es) |
| KR (1) | KR950007753B1 (es) |
| AT (1) | ATE111078T1 (es) |
| AU (1) | AU658609B2 (es) |
| CA (1) | CA2063170A1 (es) |
| CS (1) | CS89592A3 (es) |
| DE (1) | DE69200378T2 (es) |
| DK (1) | DK0506532T3 (es) |
| ES (1) | ES2064149T3 (es) |
| FR (1) | FR2674522B1 (es) |
| HU (1) | HUT65489A (es) |
| IE (1) | IE65366B1 (es) |
| IL (1) | IL101248A (es) |
| MA (1) | MA22474A1 (es) |
| MX (1) | MX9201365A (es) |
| NO (1) | NO178260C (es) |
| NZ (1) | NZ242078A (es) |
| OA (1) | OA09573A (es) |
| RU (1) | RU2074179C1 (es) |
| SI (1) | SI9210305A (es) |
| TN (1) | TNSN92022A1 (es) |
| YU (1) | YU30592A (es) |
| ZA (1) | ZA922163B (es) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2687402B1 (fr) * | 1992-02-14 | 1995-06-30 | Lipha | Nouveaux azaindoles, procedes de preparation et medicaments les contenant. |
| BR9306421A (pt) * | 1992-05-28 | 1998-09-15 | Pfizer | Novos derivados n-aril e n-heteroariluréia como inbidores da acilcoenzima a:colesterol aciltransferase (acat) |
| NZ250916A (en) * | 1993-02-27 | 1995-08-28 | Nihon Nohyaku Co Ltd | N-heteroaryl-n'-phenylureas, their use as acat inhibitors |
| IL109568A0 (en) * | 1993-05-19 | 1994-08-26 | Fujisawa Pharmaceutical Co | Urea derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof |
| DE4401893A1 (de) * | 1994-01-24 | 1995-07-27 | Bayer Ag | Substituierte Arylharnstoffe |
| JP3720395B2 (ja) | 1994-09-20 | 2005-11-24 | 京都薬品工業株式会社 | 新規ヘテロ環誘導体、その製造方法およびその医薬用途 |
| KR100241643B1 (ko) * | 1995-06-06 | 2000-03-02 | 디. 제이. 우드 | 당뇨병치료제인 치환된 N-(인돌-2-카르보닐)-β-알라님아미드 및 그의 유도체 |
| US6107329A (en) * | 1995-06-06 | 2000-08-22 | Pfizer, Inc. | Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors |
| DE69522718T2 (de) | 1995-06-06 | 2002-02-07 | Pfizer | Substituierte n-(indol-2-carbonyl)-amide und derivate als glycogen phosphorylase inhibitoren |
| AU679887B2 (en) * | 1995-09-11 | 1997-07-10 | Nihon Nohyaku Co., Ltd. | Azole derivatives, their use, production and usage |
| KR100388345B1 (ko) | 1995-10-05 | 2004-03-30 | 교토 야쿠힝 고교 가부시키가이샤 | 신규헤테로시클릭유도체및이것의의약용도 |
| EP0773218A1 (en) * | 1995-11-13 | 1997-05-14 | Mitsubishi Chemical Corporation | N-(Piperazinylalkoxyphenyl)-N'phenylalkylurea derivatives as ACAT inhibitors for the treatment of atheroschlerosis |
| FR2763334A1 (fr) * | 1997-05-13 | 1998-11-20 | Lipha | Derives anthraniliques |
| PL341231A1 (en) * | 1997-12-16 | 2001-03-26 | Warner Lambert Co | 4(3)-substitute derivatives of 4(3)aminomethyl(thio)pyrane or piperidine derivatives (analogues of garbapentin), their production and application in treating neurological disorders |
| US6518289B1 (en) * | 1997-12-16 | 2003-02-11 | Pfizer, Inc. | 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| DE69822214T2 (de) * | 1997-12-16 | 2005-03-10 | Warner-Lambert Co. Llc | ((cyclo)alkyl substituierte)-.gamma.-aminobuttersäure derivate (=gaba analoga), deren herstellung und deren verwendung bei der behandlung von neurologischen erkrankungen |
| SK282727B6 (sk) | 1997-12-19 | 2002-11-06 | Slovakofarma, A. S. | 1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy |
| US6277877B1 (en) | 2000-08-15 | 2001-08-21 | Pfizer, Inc. | Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors |
| ATE406371T1 (de) | 2000-11-02 | 2008-09-15 | Us Gov Health & Human Serv | Wirkstoffe für die verminderung von amyloid precursor protein und die behandlung von schwachsinn, und deren verfahren der verwendung |
| CA2484582A1 (en) * | 2002-05-03 | 2003-11-13 | Warner-Lambert Company Llc | Bombesin antagonists |
| RU2318808C2 (ru) * | 2002-07-17 | 2008-03-10 | Киото Фармасьютикал Индастриз, Лтд. | Новое соединение индолина и его применение в медицине |
| US7595403B2 (en) | 2003-04-01 | 2009-09-29 | Eli Lilly And Company | Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors |
| ES2329413T3 (es) | 2005-11-30 | 2009-11-25 | F. Hoffmann-La Roche Ag | 3-amino-2-arilpropil azaindoles y usos de los mismos. |
| KR20080072753A (ko) | 2005-11-30 | 2008-08-06 | 에프. 호프만-라 로슈 아게 | 3-아미노-1-아릴프로필 인돌 및 아자-치환된 인돌 |
| RU2361581C2 (ru) * | 2007-09-14 | 2009-07-20 | Закрытое Акционерное Общество "Мастерклон" | Фармацевтическая композиция, обладающая противодиабетической, гиполипидемической, гипогликемической и гипохолестеринемической активностью, способ ее получения и способы лечения указанных заболеваний |
| SK287385B6 (sk) | 2007-11-27 | 2010-08-09 | Hameln-Rds, A. S. | 1,3-Disubstituované močoviny, spôsob ich prípravy a použitia |
| CN104628621A (zh) * | 2015-01-22 | 2015-05-20 | 湖南华腾制药有限公司 | 一种氟取代吲哚衍生物的制备方法 |
| MX2019014806A (es) | 2017-06-26 | 2020-02-10 | Lunella Biotech Inc | Mitocetoscinas: agentes terapeuticos basados en mitocondrias que fijan como objetivo el metabolismo de cetonas en celulas cancerosas. |
| KR20210134689A (ko) | 2019-02-27 | 2021-11-10 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 뇌 장애를 치료하기 위한 아제피노-인돌 및 다른 헤테로사이클 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55151505A (en) * | 1979-05-14 | 1980-11-26 | Kuraray Co Ltd | Indole agricultural and horticultural fungicide |
| CA1299174C (en) * | 1987-02-02 | 1992-04-21 | Michael Edward Flaugh | Alkylmelatonins |
| EP0375133A1 (en) * | 1988-11-14 | 1990-06-27 | The Upjohn Company | Alpha-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents |
| PH30133A (en) * | 1989-09-07 | 1997-01-21 | Abbott Lab | Indole-, benzofuran-, and benzothiophene-containing lipoxygenase inhibiting compounds |
| WO1991004027A1 (en) * | 1989-09-15 | 1991-04-04 | Pfizer Inc. | New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat) |
| ATE130002T1 (de) * | 1990-08-13 | 1995-11-15 | Hoechst Roussel Pharma | 1-(pyridinylalkyl)-1h-indole, -indoline und analoge. |
| FR2680366B1 (fr) * | 1991-08-13 | 1995-01-20 | Adir | Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
| WO1993005020A1 (en) * | 1991-09-06 | 1993-03-18 | Merck & Co., Inc. | Indoles as inhibitors of hiv reverse transcriptase |
-
1991
- 1991-03-26 FR FR9103618A patent/FR2674522B1/fr not_active Expired - Fee Related
-
1992
- 1992-03-16 IL IL10124892A patent/IL101248A/en not_active IP Right Cessation
- 1992-03-17 CA CA002063170A patent/CA2063170A1/en not_active Abandoned
- 1992-03-20 EP EP92400764A patent/EP0506532B1/fr not_active Expired - Lifetime
- 1992-03-20 DK DK92400764.4T patent/DK0506532T3/da active
- 1992-03-20 DE DE69200378T patent/DE69200378T2/de not_active Expired - Fee Related
- 1992-03-20 NZ NZ242078A patent/NZ242078A/en unknown
- 1992-03-20 US US07/855,544 patent/US5219859A/en not_active Expired - Fee Related
- 1992-03-20 ES ES92400764T patent/ES2064149T3/es not_active Expired - Lifetime
- 1992-03-20 AU AU13094/92A patent/AU658609B2/en not_active Ceased
- 1992-03-20 AT AT92400764T patent/ATE111078T1/de active
- 1992-03-23 MA MA22763A patent/MA22474A1/fr unknown
- 1992-03-24 IE IE920937A patent/IE65366B1/en not_active IP Right Cessation
- 1992-03-24 NO NO921141A patent/NO178260C/no unknown
- 1992-03-25 CS CS92895A patent/CS89592A3/cs unknown
- 1992-03-25 JP JP4067252A patent/JPH0597802A/ja active Pending
- 1992-03-25 HU HU9200997A patent/HUT65489A/hu unknown
- 1992-03-25 ZA ZA922163A patent/ZA922163B/xx unknown
- 1992-03-25 RU SU925011235A patent/RU2074179C1/ru active
- 1992-03-26 KR KR1019920005020A patent/KR950007753B1/ko not_active IP Right Cessation
- 1992-03-26 MX MX9201365A patent/MX9201365A/es not_active IP Right Cessation
- 1992-03-26 YU YU30592A patent/YU30592A/sh unknown
- 1992-03-26 SI SI9210305A patent/SI9210305A/sl unknown
- 1992-03-26 OA OA60177A patent/OA09573A/fr unknown
- 1992-03-26 TN TNTNSN92022A patent/TNSN92022A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL101248A (en) | 1996-12-05 |
| IE65366B1 (en) | 1995-10-18 |
| US5219859A (en) | 1993-06-15 |
| SI9210305A (en) | 1996-02-29 |
| AU1309492A (en) | 1992-10-01 |
| RU2074179C1 (ru) | 1997-02-27 |
| MA22474A1 (fr) | 1992-10-01 |
| ZA922163B (en) | 1993-09-27 |
| YU30592A (sh) | 1994-12-28 |
| OA09573A (fr) | 1993-01-31 |
| NO178260B (no) | 1995-11-13 |
| EP0506532A1 (fr) | 1992-09-30 |
| NZ242078A (en) | 1994-10-26 |
| FR2674522A1 (fr) | 1992-10-02 |
| FR2674522B1 (fr) | 1993-07-16 |
| MX9201365A (es) | 1992-10-01 |
| CA2063170A1 (en) | 1992-09-27 |
| HU9200997D0 (en) | 1992-05-28 |
| AU658609B2 (en) | 1995-04-27 |
| TNSN92022A1 (fr) | 1993-06-08 |
| JPH0597802A (ja) | 1993-04-20 |
| ES2064149T3 (es) | 1995-01-16 |
| KR950007753B1 (ko) | 1995-07-14 |
| NO921141D0 (no) | 1992-03-24 |
| DE69200378D1 (de) | 1994-10-13 |
| ATE111078T1 (de) | 1994-09-15 |
| IE920937A1 (en) | 1992-10-07 |
| KR920018022A (ko) | 1992-10-21 |
| EP0506532B1 (fr) | 1994-09-07 |
| DE69200378T2 (de) | 1995-03-09 |
| NO178260C (no) | 1996-02-21 |
| NO921141L (no) | 1992-09-28 |
| DK0506532T3 (da) | 1995-02-20 |
| HUT65489A (en) | 1994-06-28 |
| IL101248A0 (en) | 1992-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS89592A3 (en) | Novel indole derivative, process of its preparation and a pharmaceuticalcomprising thereof | |
| US5905080A (en) | Amide and urea derivatives as 5HT1D receptor antagonists | |
| US5338849A (en) | Azaindoles, preparation processes and medicinal products containing them | |
| CA3069720A1 (en) | Carboxamides as modulators of sodium channels | |
| JP2019522005A (ja) | 芳香族アセチレンまたは芳香族エチレン系化合物、その中間体、製造方法、薬物組成物および使用 | |
| AU2017254916A1 (en) | Method for producing substituted 5-fluoro-1H-pyrazolopyridines | |
| CS402991A3 (en) | Dichloroaniline derivatives, process of their preparation andpharmaceutical compositions comprising them | |
| SE451017B (sv) | Cinnamylmoranolin-derivat | |
| WO2012127385A1 (en) | Benzo [b] [1, 4] oxazin derivatives as calcium sensing receptor modulators | |
| HU198916B (en) | Process for producing new thiazol derivatives active for the colinerg systhem and pharmaceutical compositions containing them | |
| DK160820B (da) | Analogifremgangsmaade til fremstilling af 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)quinolinderivater | |
| JP5852269B2 (ja) | Ｍｏｇａｔ−２阻害剤として有用な新規モルホリニル誘導体 | |
| CZ301770B6 (cs) | Dibenzoazulenové deriváty jako inhibitory rakovinných nekróz a farmaceutický prostredek je obsahující | |
| DK143128B (da) | Analogifremgan&smaade til fremstilling af 1-aryloxy-2-hydroxy-3-alkylaminopropaner eller deres fysiologisk acceptable syreadditionssalte | |
| US20040006232A1 (en) | Pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds | |
| Manoury et al. | Synthesis and analgesic activities of some (4-substituted phenyl-1-piperazinyl) alkyl 2-aminobenzoates and 2-aminonicotinates | |
| NO326986B1 (no) | Antranilsyreamider, fremgangsmate for fremstilling derav, anvendelse av forbindelsene samt farmasoytisk preparat | |
| Dallanoce et al. | Synthesis of enantiopure Δ2-isoxazoline derivatives and evaluation of their affinity and efficacy profiles at human β-adrenergic receptor subtypes | |
| US7119122B2 (en) | Compounds for the inhibition of nitric oxide synthase | |
| US3850947A (en) | 3-thiazol-4'-oxy-aminopropanol cardiovascular agents | |
| CS249145B2 (en) | Method of new beta-cycloalkyl-beta-phenylethylamines' production | |
| DK145225B (da) | Analogifremgangsmaade til fremstilling af 1-(3-trimethoxyphenoxy-2-hydroxy-propyl)-4-phenyl-piperazinderivater eller syreadditionssalte deraf | |
| NO881899L (no) | Nye 2-aminoalkyl-4-benzyl-1-(2h)-ftalazino-derivater. | |
| NO136841B (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive fenylimidazolidinoner. | |
| US20060270714A1 (en) | Novel n-substituted 2-aminopyridine derivatives |